65,437 trials
Serum CNP Levels · Healthy Reproductive Age Women · Healthy Perimenopausal Women
Primary: Serum C Type Natriuretic Peptide Levels — 43.68; 55.98; 116.36 pg/ml — p=<0.017
Gastric or Duodenal Ulcers
Primary: Percentage of Participants Who Had One or More Adverse Drug Reactions — 1.79 Percentage of Participants
Anxiety · Educational Problems
Primary: The Situational-Continuous Anxiety Inventory — 44; 43; 56 score on a scale
Asthma
Primary: Number of Emergency Room Visits Secondary to Asthma Exacerbation — 0.31; 0.33 visits
Prostate Cancer
Primary: Change From Baseline in Functional Assessment of Cancer Therapy - Prostate (FACT-P) Total Score at 12 Months — -8.04; -6.60; -9.42 Units on a scale
Hematological Malignancies
Primary: Percentage of GI Toxicity From the Preparatory Regimen and the GVHD Prophylaxis in Stem Cell Transplantation (SCT) Patients Who Are Treated With Pasireotide — 21…
Major Depressive Disorder · Suicidal Ideation
Primary: Change in Scale for Suicidal Ideation — -3.66; -8.62 units on a scale
Photoallergy
Primary: Within-subject Comparison of Dermal Reaction by the Overall Numeric Rating of Erythema and Edema at 5 Defined Test Sites, After Application of MC2-01 Cream, MC2-01…
Mitral Regurgitation
Primary: Number of Participants With Major Serious Adverse Events and Serious Adverse Device Effects — 2; 1; 2; 4 Participants
Catheter Complications
Primary: Duration of IV Survival — 92; 136 hours
Hepatitis C
Primary: Sustained Virologic Response (SVR12) Rate — 38 Participants
Intra-subject Variability of Pharmacokinetics
Primary: Cmax — 0.961; 2.34; 23.6; 1.02 ng/mL
Colonoscopy · Adjunct Anesthesia Medication
Primary: Dosage of Fentanyl — 125.4; 126.9 (μg)
Cardiovascular Disease
Primary: Proportion of Subjects With ECM Related Adverse Events — 14; 2 Participants
High Utilizers of Hospital Care
Primary: Any Hospital Readmission — 240; 245 Participants